SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-14-054116
Filing Date
2014-07-29
Accepted
2014-07-29 06:01:21
Documents
12
Period of Report
2014-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q a14-14069_110q.htm 10-Q 1558563
2 EX-10.1 a14-14069_1ex10d1.htm EX-10.1 44378
3 EX-31.1 a14-14069_1ex31d1.htm EX-31.1 13171
4 EX-31.2 a14-14069_1ex31d2.htm EX-31.2 13128
5 EX-32.1 a14-14069_1ex32d1.htm EX-32.1 7421
6 EX-32.2 a14-14069_1ex32d2.htm EX-32.2 7428
  Complete submission text file 0001104659-14-054116.txt   9941569

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT uthr-20140630.xml EX-101.INS 1610762
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT uthr-20140630.xsd EX-101.SCH 67554
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT uthr-20140630_cal.xml EX-101.CAL 89899
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT uthr-20140630_def.xml EX-101.DEF 250326
11 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT uthr-20140630_lab.xml EX-101.LAB 717355
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT uthr-20140630_pre.xml EX-101.PRE 460048
Mailing Address 1040 SPRING ST SILVER SPRING MD 20910
Business Address 1040 SPRING ST SILVER SPRING MD 20910 3016089292
UNITED THERAPEUTICS Corp (Filer) CIK: 0001082554 (see all company filings)

IRS No.: 521984749 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-26301 | Film No.: 14998009
SIC: 2834 Pharmaceutical Preparations